Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
21 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/21/3030444/21662/en/Tempus-and-Stemline-Therapeutics-Inc-A-Subsidiary-of-the-Menarini-Group-Announce-Collaboration-to-Implement-Tempus-Next-an-AI-Enabled-Care-Pathway-Intelligence-Platform-to-Support-.html
11 Dec 2024
// BUSINESSWIRE
04 Jan 2024
// Gabrielle Masson FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/menarini-groups-stemline-inks-500m-biobucks-deal-insilicos-breast-cancer-candidate
09 Oct 2023
// EMA
https://www.ema.europa.eu/en/documents/overview/orserdu-epar-medicine-overview_en.pdf
21 Sep 2023
// BUSINESSWIRE
https://www.businesswire.com/news/home/20230920907427/en/European-Commission-Approves-Menarini-Group%E2%80%99s-ORSERDU%C2%AE-Elacestrant-for-the-Treatment-of-Patients-with-ER-HER2--Locally-Advanced-or-Metastatic-Breast-Cancer-with-an-Activating-ESR1-Mutation
30 Aug 2023
// BUSINESSWIRE
ABOUT THIS PAGE